Abass alavi biography of abraham
Home / Celebrity Biographies / Abass alavi biography of abraham
He has trained and mentored countless students in modern imaging techniques, and many of his former students and research fellows now occupy leadership positions in medical imaging across the world.
- 1971-1973: Fellow, Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia
- 1973-1974: Instructor in Radiology, Dept.
of Radiology, Univ. In August 1976, he was part of the team that performed the first human PET studies of the brain and whole body using the radiotrace. In addition, FDG has resulted in the exploration of numerous biologically important compounds in research and drug development.
Awards, honors and membership in honorary societies
Alavi is the recipient of many awards and distinctions,[3] among which are the highest distinctions in nuclear medicine: the Georg Charles de Hevesy Nuclear Pioneer Award [4] given by the Society of Nuclear Medicine, the Cassen Prize of the Society of Nuclear Medicine, and honorary degrees from the University of Bologna, the University of the Sciences in Philadelphia and Shiraz University in Iran.
After graduating from high school in Tabriz, Alavi moved to Tehran and received his medical degree from the Tehran University of Medical Sciences in 1964.He began his training in internal medicine at the Albert Einstein Medical Center and the Philadelphia VA Hospital in 1966. Hell J Nucl Med. 2018 Jan-Apr;21(1):85-87. This award is announced annually at the Shaukat Khanum Cancer Symposium.
Read more on source:
https://en.wikipedia.org/wiki/Abass_Alavi
Dr.
Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research Education in the Department of Radiology at the University of Pennsylvania. Following subspecialization in hematology/oncology at the University of Pennsylvania, Alavi started his education in medical imaging by enrolling in the radiology department at the Harvard-affiliated Beth Israel Deaconess Medical Center.
He joined the University of Pennsylvania School of Medicine in 1971 as a research fellow in nuclear medicine, and was soon appointed to the faculty.
of Radiology, Univ. In 1973, he—along with his colleagues Dr. Kuhl and Dr. Martin Reivich—were the first scientists to conceive the idea of labeling deoxyglucose with positron-emitting fluoride (F-18), leading to the development of FDG. In August 1976, Alavi became the first to administer FDG to a human being and acquire tomographic images of the brain and whole body.
The system detects pairs of gamma rays emitted as a result of the annihilation of positrons emitted from radionuclides (tracers), which are used to label biologically active molecules.
One of the factors most responsible for the widespread adoption of positron imaging was the development of radiopharmaceuticals. He did his post-graduate training as an intern (1966-1967) and first year resident (1967-1968) at Albert Einstein Medical Center in Philadelphia, a second year residency in medicine (1968-1969) at Veterans Administration Hospital in Philadelphia, a fellowship in hematology (1969-1970) at the Hospital of the University of Pennsylvania, a residency in radiology (1970-1971) at Beth Israel Hospital in Boston, and a fellowship in nuclear medicine (1971-1973) at the Hospital of the University of Pennsylvania.
Dr.
He was also among the first to utilize Iodine-123 in the diagnosis of thyroid cancer, MIBG in the assessment of pheochromocytoma, radiolabled WBCs in the evaluation of infection, and 99mTc in the detection of gastrointestinal bleeds, among a host of other discoveries.
Alavi has been associated with the University of Pennsylvania for all of his career, beginning with a fellowship in Nuclear Medicine in 1971–1973.
Alavi received his medical degree from University of Tehran School of Medicine in 1964. He is currently the Director of Research Education in the Division of Nuclear Medicine at the University of Pennsylvania. of Radiology, Univ. of Psychiatry, University of Maryland
Other appearances
Alavi has been a long-time supporter of educational and research opportunities for students in nuclear medicine.
of Pennsylvania School of Medicine
[1] Høilund-Carlsen PF.
Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong! Abass Alavi is a Professor of Radiology and Associate Director at the Institute on Aging at the University of Pennsylvania Perelman School of Medicine.
Dr.
Alavi is recognized as a pioneer in molecular and nuclear imaging, having contributed to the development of positron emission tomography (PET), in particular utilizing the radiotracer 18F fluorodeoxyglucose (FDG) in PET imaging, and later using 18F-FDG-PET in conjunction with computed tomography (CT) and magnetic resonance imaging (MRI) to understand diseases.
Working under the guidance of Dr.
David Kuhl, Dr. Alavi and colleagues were pioneers in performing modern tomographic imaging by utilizing single gamma emitting radionuclides-- single photon emission computer tomography (SPECT).
In 1973, Drs. Alavi, Kuhl and Reivich devised the concept of labeling deoxyglucose with positron-emitting fluroide (18F), which lead to the development of FDG, the first clinically approved radiopharmaceutical for PET imaging that is still widely used today.
In August 1976, Dr.
Alavi was part of the team, with mentor Dr. Kuhl, that performed the first human PET studies of the brain and whole body using18F-FDG. [1] He also was among the first to utilize iodine-123 in the diagnosis of thyroid cancer, meta-iodobenzylguanidine in the assessment of pheochromocytoma, radiolabled white blood cells in the evaluation of infection, and technetium 99m in the detection of gastrointestinal bleeds.